Opportunities for long-range magnon-mediated entanglement of spin qubits via on- and off-resonant coupling

The ability to manipulate entanglement between multiple spatially-separated qubits is essential for quantum information processing. Although nitrogen-vacancy (NV) centers in diamond provide a promising qubit platform, developing scalable two-qubit gates remains a well-known challenge. To this end, magnon-mediated entanglement proposals have attracted attention due to their long-range spin-coherent propagation. Optimal device geometries and gate protocols of such schemes, however, have yet to be determined. Here we predict strong long-distance ($>\mu$m) NV-NV coupling via magnon modes with cooperativities exceeding unity in ferromagnetic bar and waveguide structures. Moreover, we explore and compare on-resonant transduction and off-resonant virtual-magnon exchange protocols, and discuss their suitability for generating or manipulating entangled states at low temperatures ($T\lesssim 150$ mK) under realistic experimental conditions. This work will guide future experiments that aim to entangle spin qubits in solids with magnon excitations.Comment: PRX Quantum in press, 10 pages, 5 figure

Avaliacao genetica e selecao em Eucalyptus grandis na regiao de Arapoti - PR.

Foram avaliados 17.916 indivíduos, pertencentes a 163 progênies de polinização aberta de 11 populações de Eucalyptus grandis, implantadas em duas fazendas na região de Arapoti - PR, visando a seleção de indivíduos com base em seus valores genéticos preditos. Foram obtidas estimativas médias da herdabilidade no sentido restrito, em nível de indivíduos e da acurácia seletiva, da ordem de 40 e 65%, respectivamente. A estimativa (0,75) da correlação genética entre médias de progênies, nas duas fazendas, indicou que a interação genótipo X ambiente não é problemática para o melhorista. Ganhos genéticos da ordem de 87 a 105% poderão ser obtidos com o estabelecimento das populações de melhoramento e de produção de sementes, respectivamente

Engineering copper nanoparticle electrodes for tunable electrochemical reduction of carbon dioxide

The electrochemical conversion of CO2 catalyzed by copper (Cu)-based materials is widely reported to produce different valuable molecules, and the selectivity for a specific product can be achieved by tuning the characteristics of catalytic materials. Differing from these studies on materials, the present work focuses on the engineering of gas diffusion electrodes in order to properly modify the selectivity, particularly by changing the Cu nanoparticle catalyst loading of the electrodes. Low catalyst loadings (≤ 0.25 mg cm−2) favor CH4 production, and intermediate (∼ 1.0 mg cm−2) loadings shift the selectivity toward C2H4. Eventually, larger values (≥ 2.0 mg cm−2) promote CO production. Detailed analyses reveal that both bulk and local CO generation rates, and charge transfer mechanism are responsible for the observed loading-dependent selectivity. The present work provides a new strategy for steering the CO2RR selectivity by simple electrode engineering beyond material development

Highly Dispersed Few-Nanometer Chlorine-Doped SnO2 Catalyst Embedded in a Polyaniline Matrix for Stable HCOO– Production in a Flow Cell

With the spread of alternative energy plants, electrolysis processes are becoming the protagonists of the future industrial generation. The technology readiness level for the electrochemical reduction of carbon dioxide is still low and is largely based on precious metal resources. In the present work, tin ions are anchored on a polyaniline matrix, via a sonochemical synthesis, forming a few atomic layers of chlorine-doped SnO2 with a total loading of tin atom load of only 7 wt %. This catalyst is able to produce formate (HCOO-) with great selectivity, exceeding 72% of Faradaic efficiency in the first hour of testing in 1 M KHCO3 electrolyte, with a current density of more than 50 mA cm-2 in a 2 M KHCO3 electrolyte flow cell setup. Catalyst stability tests show a stable production of HCOO- during 6 h of measurement, accumulating an overall TONHCOO- of more than 10,000 after 16 h of continuous formate production. This strategy is competitive in drastically reducing the amount of metal required for the overall catalysis

The Effect of Once-Daily Gabapentin Extended Release Formulation in Patients With Postamputation Pain

ObjectivesTo compare gabapentin extended-release, a gastro-retentive formulation, in relieving postamputation pain among gabapentin-experienced and gabapentin-naïve patients.DesignOpen-labeled pilot study.SubjectsSixteen patients with postamputation pain (8 patients in the gabapentin-experienced and 8 patients in the gabapentin-naïve groups).MethodsPatients were started on gabapentin extended-release and were followed up for 8 weeks. Patients reported their pain severity during rest and movement using a numeric rating scale (NRS), interference of pain with daily activities using the modified brief pain inventory (MBPI) questionnaire, and treatment satisfaction using the treatment satisfaction questionnaire for medication (TSQM).ResultsPatients from both gabapentin-experienced and gabapentin-naïve groups achieved a significant and sustainable pain relief over the course of therapy. The pain scores at rest decreased in both gabapentin-experienced and gabapentin-naïve groups from 5.88 ± 1.36 and 4.88 ± 2.95 to 1.88 ± 0.99 and 1.38 ± 1.51, respectively. An average percent of pain relief with gabapentin extended-release was noted to be significant (p < 0.01) after 8 weeks of therapy among gabapentin-experienced (81.25 ± 16.42%) and gabapentin-naïve groups (85 ± 17.73%) when compared to baseline for gabapentin-experienced (31.25 ± 29%) and gabapentin-naïve groups (36.25 ± 34.2%), respectively. Gabapentin-experienced and gabapentin-naïve groups had no significant difference in global satisfaction from treatment (79.14 ± 10.47 and 83.3 ± 20.82), convenience of treatment (73.78 ± 19.04 and 90.44 ± 11.66), effectiveness of treatment (72.6 ± 10.1 and 79.73 ± 11.6). The only statistically significant difference among gabapentin-experienced and gabapentin-naïve groups was found in adverse event tolerability (65.78 ± 10.36 and 85.8 ± 10.14, p < 0.01).ConclusionOnce-daily dosing of gabapentin-extended release showed significant improvement in pain severity and functional status, with no difference found between gabapentin-experienced versus gabapentin-naïve patients

Parton Distributions and New Physics Searches: the Drell-Yan Forward-Backward Asymmetry as a Case Study

We discuss the sensitivity of theoretical predictions of observables used in searches for new physics to parton distributions (PDFs) at large momentum fraction $x$. Specifically, we consider the neutral-current Drell-Yan production of gauge bosons with invariant masses in the TeV range, for which the forward-backward asymmetry of charged leptons from the decay of the gauge boson in its rest frame is a traditional probe of new physics. We show that the qualitative behaviour of the asymmetry depends strongly on the assumptions made in determining the underlying PDFs. We discuss and compare the large-$x$ behaviour of various different PDF sets, and find that they differ significantly. Consequently, the shape of the asymmetry observed at lower dilepton invariant masses, where all PDF sets are in reasonable agreement because of the presence of experimental constraints, is not necessarily reproduced at large masses where the PDFs are mostly unconstrained by data. It follows that the shape of the asymmetry at high masses may depend on assumptions made in the PDF parametrization, and thus deviations from the traditionally expected behaviour cannot be taken as a reliable indication of new physics. We demonstrate that forward-backward asymmetry measurements could help in constraining PDFs at large $x$ and discuss the accuracy that would be required to disentangle the effects of new physics from uncertainties in the PDFs in this region.Comment: 27 pages, 20 figure

Do Corticosteroids Still Have a Place in the Treatment of Chronic Pain?

Corticosteroids have played a standard role in the multimodal pain management in the treatment of chronic spinal pain (cervical and lumbar) and osteoarthritis pain over the past three decades. In this review we discuss different types of injectable steroids that are mainly used for injection into the epidural space (for the treatment of radicular back and neck pain), and as intra-articular injections for different types of osteoarthritis related pain conditions. Furthermore, we discuss different approaches taken for epidural corticosteroid injections and spinal surgical rates when injections fail to resolve painful conditions, as well as the possibility of using local anesthetics alone for neuraxial injections, instead of in combination with corticosteroids. While we present some beneficial effects of newly available treatment options for low back pain and osteoarthritis pain, such as use of PRP and hyaluronic acid, corticosteroids remain important considerations in the management of these chronic pain conditions